Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Humer is a prominent consumer healthcare brand specializing in respiratory and ENT (Ear, Nose, and Throat) solutions, primarily known for its range of nasal hygiene products. Owned by Laboratoires Urgo, the brand offers a diverse portfolio including isotonic and hypertonic seawater sprays, treatments for allergic rhinitis, and remedies for coughs and sore throats. Humer emphasizes natural-based formulations, such as undiluted seawater and plant extracts, to provide effective relief for common respiratory ailments. The brand is a market leader in France and has a significant international presence in the over-the-counter (OTC) pharmaceutical sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Humer.